1 |
Beaulieu, D., J. Tang, S. B. Yan, J. M. Vessels, J. A. Radding, and T. R. Parr, Jr. 1994. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)--D-glucan synthase. Antimicrob. Agents Chemother. 38: 937-944.
DOI
|
2 |
Blankenship, J. R. and A. P. Mitchell. 2006. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9: 588-594.
DOI
ScienceOn
|
3 |
Calderone, R. A. and P. C. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55: 1-20.
|
4 |
Calderone, R. A. and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9: 327-335.
DOI
ScienceOn
|
5 |
Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
DOI
ScienceOn
|
6 |
CLSI. 2008a. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition; CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne.
|
7 |
Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahl, P. Mazur, W. Baginsky, W. Li, and M. el-Sherbeini. 1994. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1, 3- -D-glucan synthase. Proc. Natl. Acad. Sci. U.S.A. 91: 12907- 12911.
DOI
ScienceOn
|
8 |
Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11: 30-36.
DOI
ScienceOn
|
9 |
Guarrera, P. M. 2005. Traditional phytotherapy in central Italy. Fitotherapia 76: 1-25.
DOI
ScienceOn
|
10 |
Haynes, K. 2001. Virulence in Candida species. Trends Microbiol. 9: 591-596.
DOI
ScienceOn
|
11 |
Henry-Stanley, M. J., R. M. Garni, and C. L. Wells. 2004. Adaptation of FUN-1 and Calcofluor white stains to assess the ability of viable and nonviable yeast to adhere to and be internalized by cultured mammalian cells. J. Microbiol. Methods 59: 289-292.
DOI
ScienceOn
|
12 |
Huang, W. H., Lee, A. R., and C. H. Yang. 2006. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci. Biotechnol. Biochem. 70: 2371-2380.
DOI
ScienceOn
|
13 |
Klis, F. M., A. F. J. Ram., and P. W. J. De Groot. 2007. A molecular and genomic view of the fungal cell wall. The Mycota 8: 97-120.
DOI
|
14 |
Liu, M., V. Seidel, D. R. Katerere, and A. I. Gray. 2007. Colorimetric broth microdilution for the antifungal screening of plant extracts against yeast. Methods 42: 325-329.
DOI
ScienceOn
|
15 |
Kolotila, M. P., C. W. Smith, and A. L. Rogers. 1987. Candidacidal activity of macrophages from three mouse strains as demonstrated by a new method: neutral red staining. Med. Mycol. 25: 283-290
DOI
|
16 |
Krcmery, V. and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50: 243-260.
DOI
ScienceOn
|
17 |
Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, and J. M. Balkovec. 1994. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother. 38: 2750-2757.
DOI
ScienceOn
|
18 |
Mahmoud, A. G. and B. R. Louis. 1999. Antifungal agents: mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12: 501-517.
|
19 |
Millard, P. J., B. L. Roth, H. -P. Thi, S. T. Yue, and R. P. Haugland. 1997. Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeast. Appl. Environ. Microbiol. 63: 2897-2905.
|
20 |
O'Brien, J., J. Wilson, T. Orton, and F. Pognan. 2000. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267: 5421-5426.
DOI
ScienceOn
|
21 |
Oliver, B. G., P. M. Silver, C. Marie, S. J. Hoot, S. E. Leyde, and T. C. White. 2008. Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiol. 154: 960-970.
DOI
ScienceOn
|
22 |
Ramage, G., K. Vande-Walle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45: 2475-2479.
DOI
ScienceOn
|
23 |
Park, S. J., S. J. Choi, W. S. Shin, H. M. Lee, K. S. Lee, and K. H. Lee. 2009. Relationship between biofilm formation ability and virulence of Candida albicans. J. Bacteriol. Virol. 39: 119-124.
DOI
|
24 |
Pfaller, M. A. and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20: 133-163.
DOI
ScienceOn
|
25 |
Ramage, G., J. P. Martinez, and J. L. Lopez-Ribot. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6: 979-986.
DOI
ScienceOn
|
26 |
Roling, E. E., M. E. Klepser, A. Wasson, R. E. Lewes, E. J. Ernst, and M. A. Pfaller. 2002. Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY303366) alone and in combination against Candida spp. and Cryotococcus neoformans via time-kill methods. Diagn. Microbial. Infec. Dis. 43: 13-17.
DOI
ScienceOn
|
27 |
Shedletzky, E., C. Unger, and D. P. Delmer. 1997. A microtiterbased fluorescence assay for (1,3)--glucan synthases. Anal. Biochem. 249: 88-93.
DOI
ScienceOn
|
28 |
Tang, J. and T. R. Parr, Jr. 1991. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)--D-glucan synthase. Antimicrob. Agents Chemother. 35: 99-103.
DOI
|
29 |
Yoon, S. B., Y. J. Lee, S. K. Park, H. C. Kim, H. Bae, H. M. Kim, S. G. Ko, H. Y. Choi, M. S. Oh, and W. Park. 2009. Anti-inflammatory effects of Scutellaria baicalensis water extract on LPSactivated RAW 264.7 macrophages. J. Ethnopharmacol. 125: 286-290.
DOI
ScienceOn
|